Classification of Osteogenesis Imperfecta revisited

European Journal of Medical Genetics

Volumn 53, Issue 1, 2010, Pages 1-5

  Van Dijk, F S ^a   Pals, G ^a   Van Rijn, R R ^b   Nikkels, P G J ^c   Cobben, J M ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b EMMA CHILDREN S HOSPITAL   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOSOMAL RECESSIVE INHERITANCE; CLINICAL FEATURE; DISEASE CLASSIFICATION; GENE MUTATION; HISTOLOGY; HUMAN; OSTEOGENESIS IMPERFECTA; RADIOLOGY; REVIEW;

GENES, RECESSIVE; HUMANS; MUTATION; OSTEOGENESIS IMPERFECTA;

EID: 74149085374     PISSN: 17697212     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejmg.2009.10.007     Document Type: Review

References (29)

1. Baldridge D., Schwarze U., Morello R., Lennington J., Bertin T., Pace J., Pepin M., Weis M., Eyre D., Walsh J., Lambert D., Green A., Robinson H., Michelson M., Houge G., Lindman C., Martin J., Ward J., Lemyre E., Mitchell J., Krakow D., Rimoin D., Cohn D., Byers P., and Lee B. CRTAP and LEPRE1 mutations in recessive osteogenesis imperfecta. Hum. Mutat. 29 (2008) 1435-1442
2. Barnes A., Chang W., Morello R., Cabral W., Weis B., Eyre D., Leikin S., Makareeva E., Kuznetsova N., Uveges T., Ahok A., Flor A., Mulvihill, Wilson P.L., Sundaram U., Lee B., and Marini J. Deficiency of cartilage-associated protein in recessive lethal osteogenesis imperfecta. N. Engl. J. Med. 355 (2006) 2757-2764
3. Bauze R., Smith R., and Francis M. An new look at osteogenesis imperfecta: a clinical, radiological and biochemical study of forty-two patients. J. Bone Joint Surg. 57-B (1975) 1415-1425
4. Byers P., and Steiner R. Osteogenesis imperfecta. Annu. Rev. Med. 43 (1992) 269-282
5. Byers P., Wallis G., and Willing M. Osteogenesis Imperfecta: translation of mutation to phenotype. J. Med. Genet. 28 (1991) 433-442
6. Cabral W., Chang W., Barnes A., Weis M., Scott M., Leikin S., Makareeva E., Kuznetsova N., Rosenbaum K., Tifft C., Bulas D., Kozma C., Smith P., Eyre D., and Marini J. Prolyl 3-hydroxylase 1 deficiency causes a recessive metabolic bone disorder resembling lethal/severe osteogenesis imperfecta. Nat. Genet. 39 (2007) 359-365
7. Cobben J., Cornel M., Dijkstra I., and Ten Kate L. Prevalence of lethal osteochondrodysplasias. AJMG 36 (1990) 377-378
8. F. van Dijk, I. Nesbitt, P. Nikkels, A. Dalton, E. Bongers, J. van de Kamp, Y. Hilhorst-Hofstee, N. den Hollander, A. Lachmeijer, C. Marcelis, M. Tan-Sindhunata, R. van Rijn, H. Meijers-Heijboer, J. Cobben, G. Pals, CRTAP mutations in lethal and severe osteogenesis imperfecta: the importance of combining biochemical and molecular genetic analysis, EJHG, Epub ahead of print.
9. F. van Dijk, I. Nesbitt, E. Zwikstra, P. Nikkels, S. Piersma, S. Fratantoni, C. Jimenez, M. Huizer, A. Morsman, J. Cobben, M. van Roij, M. Elting, J. Verbeke, L. Wijnaendts, N. Shaw, W. Högler, C. McKeown, E. Sistermans, A. Dalton, H. Meijers-Heijboer, G. Pals, PPIB mutations cause severe osteogenesis imperfecta, AJHG, Epub ahead of print.
10. Fleming F., Woodhead H., Briody J., Hall J., Cowell C., Ault J., Kozlowski K., and Sillence D. Cyclic biphosphonate therapy in osteogenesis imperfecta type V. J. Paediatr. Child Health 41 (2005) 147-151
11. Glorieux F., Rauch F., Plotkin H., Ward L., Travers R., Roughley, Lalic L., Glorieux D., Fassier F., and Bishop N. Type V osteogenesis imperfecta: a new form of brittle bone disease. J. Bone Miner. Res. 15 (2000) 1650-1658
12. Glorieux F., Ward L., Rauch F., Lalic L., Roughley P., and Travers R. Osteogenesis imperfecta type VI: a form of brittle bone disease with mineralization defect. J. Bone Miner. Res. 17 (2002) 30-37
13. Labuda M., Morissette J., Ward, Rauch F., Lalic L., Roughley P., and Glorieux F. Osteogenesis imperfecta type VII maps to the short arm of chromosome 3. Bone 31 (2002) 19-25
14. Land C., Rauch F., Travers R., and Glorieux F. Osteogenesis imperfecta type VI in childhood and adolescence: effects of cyclical intravenous pamidronate treatment. Bone 40 (2007) 638-644
15. Lee D., Cho T., Choi I., Chung C., Yoo W., Kim J., and Park Y. Clinical and radiological manifestations of osteogenesis imperfecta. J. Korean Med. Sci. 21 (2006) 709-714
16. Marini J., Cabral W., Barnes A., and Chang W. Components of the collagen prolyl-3-hydroxylation complex are crucial for normal bone development. Cell Cycle 6 (2007) 1675-1681
17. Marini J., Forlino A., Cabral W., Barnes A., San Antonio J., Milgrom S., Hyland J., Körkkö J., Prockop D., de Paepe A., Coucke P., Symoens S., Glorieux F., Roughely P., Lund A., Kuurila-Svahn K., Hartikka H., Cohn D., Krakow D., Mottes M., Schwarze U., Chen D., Yang K., Kuslich C., Troendle J., Dalgleish R., and Byers P. Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sides for integrins and proteins. Hum. Mutat. 28 (2007) 209-221
18. Marini J., Grange D., Gottesman G., Lewis M., and Koeplin D. Osteogenesis imperfecta type IV. Detection of a point mutation in one alpha1(I) collagen allele (Col1a1) by RNA/RNA hybrid analysis. J. Biol. Chem. 264 (1989) 11893-11900
19. Morello R., Bertin T., Chen Y., Hicks J., Tonachini L., Monticone M., Castagnola P., Rauch F., Glorieux F., Vranka J., Bächinger H.P., Pace J., Schwarze U., Byers P., Weis M., Fernandes R., Eyre D., Yao Z., Buyce B., and Lee B. CRTAP is required for prolyl 3-hydroxylation and mutations cause autosomal recessive osteogenesis imperfecta. Cell 127 (2006) 291-304
20. Obafemi A., Bulas D., Troendle J., and Marini C. Popcorn calcifications in osteogenesis imperfecta: incidence, progression, and molecular correlation. AJMG 146A (2008) 2725-2732
21. Online Mendelian Inheritance in Man, OMIM (TM). Johns Hopkins University, Baltimore, MD. MIM number:{ #610915}: {7/14/2008} and MIM number:{ #610854}:{3/19/2007}: World Wide Web URL: http://www.ncbi.nlm.nih.gov/omim/
22. Rauch F., and Glorieux F. Osteogenesis imperfecta. Lancet 363 (2004) 1377-1385
23. Sillence D., Barlow K., Garber A., Hall J., and Rimoin D. Osteogenesis imperfecta type II delineation of the phenotype with reference to genetic heterogeneity. Am. J. Med. Genet. 17 (1984) 407-423
24. Sillence D., Senn A., and Danks D. Genetic heterogeneity in osteogenesis imperfecta. J. Med. Genet. 16 (1979) 101-116
25. Spranger J., Brill P., and Poznanski A. Section X: skeletal dysplasias with prominent diaphyseal involvement, Osteogenesis imperfecta, type III/ IIB. In: Spranger J., Brill P., and Poznanski A. (Eds). Bone Dysplasias. An Atlas of Genetic Disorders of Skeletal Development (2003), Oxford University Press, Oxford 440-441
26. R. Steiner, M. Pepin, P. Byers, Osteogenesis Imperfecta.www.genetests.com
27. Wallis G., Sykes B., Byers P., Mathew C., Viljoen D., and Beighton P. Osteogenesis imperfecta type III: mutations in the type I collagen structural genes, COL1A1 and COL1A2, are not necessarily responsible. J. Med. Genet. 30 (1993) 492-496
28. Ward L., Rauch F., Travers R., Chabot G., Azouz E., Lalic L., Roughley P., and Glorieux F. Osteogenesis Imperfecta type VII an autosomal recessive form of brittle bone disease. Bone 31 (2002) 12-18
29. Zeitlin L., Rauch F., Travers R., Munns C., and Glorieux F. The effect of cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta type V. Bone 38 (2006) 13-20